Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $365.88 | 22 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $135.25 | 8 | $0 (2022) |
| GlaxoSmithKline, LLC. | $112.41 | 7 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $48.91 | 3 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $37.28 | 2 | $0 (2022) |
| Gilead Sciences, Inc. | $32.03 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $269.02 | 16 | ABBVIE INC. ($135.25) |
| 2021 | $43.76 | 3 | GlaxoSmithKline, LLC. ($43.76) |
| 2020 | $25.76 | 1 | GlaxoSmithKline, LLC. ($25.76) |
| 2019 | $27.34 | 2 | GlaxoSmithKline, LLC. ($27.34) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/28/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: DIABETES | ||||||
| 06/15/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: NEUROSCIENCE | ||||||
| 06/03/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: PRIMARY CARE | ||||||
| 05/24/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $12.69 | General |
| 04/29/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2022 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: ONC | ||||||
| 03/30/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.36 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: IMMUNOLOGY | ||||||
| 03/15/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: NEUROSCIENCE | ||||||
| 03/04/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: NEUROSCIENCE | ||||||
| 02/18/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: NEUROSCIENCE | ||||||
| 02/10/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: PRIMARY CARE | ||||||
| 02/09/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.01 | General |
| 01/25/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: DIABETES | ||||||
| 01/07/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: NEUROSCIENCE | ||||||
| 08/25/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: IMMUNOLOGY | ||||||
| 05/26/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: RESPIRATORY | ||||||
| 01/27/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: RESPIRATORY | ||||||
| 07/24/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: RESPIRATORY | ||||||
| 07/24/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: RESPIRATORY | ||||||
About Dr. Dakota Lammy, MD
Dr. Dakota Lammy, MD is a Family Medicine healthcare provider based in Pittsfield, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2019. The National Provider Identifier (NPI) number assigned to this provider is 1780147314.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dakota Lammy, MD has received a total of $365.88 in payments from pharmaceutical and medical device companies, with $269.02 received in 2022. These payments were reported across 22 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($365.88).
Practice Information
- Specialty Family Medicine
- Location Pittsfield, IL
- Active Since 04/10/2019
- Last Updated 09/09/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1780147314
Products in Payments
- VRAYLAR (Drug) $135.25
- TRELEGY ELLIPTA (Drug) $82.33
- NURTEC ODT (Drug) $37.28
- JARDIANCE (Drug) $36.22
- NUCALA (Biological) $30.08
- Trodelvy (Drug) $16.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Pittsfield
Eugene Heyman, M.d, M.D
Family Medicine — Payments: $9,620
Dr. Giro Samale, M.d, M.D
Family Medicine — Payments: $3,180
Devin Croft, Md, MD
Family Medicine — Payments: $196.63
Dr. Mohammad Shareef, M.d, M.D
Family Medicine — Payments: $139.78
Dr. Ronald Johnson, Md, MD
Family Medicine — Payments: $98.48
Paulius Mui, Md, MD
Family Medicine — Payments: $73.64